Pfizer (PFE)
$28.05
0.35 (1.26%)
PFE Stock Quote Delayed 30 Minutes
Pfizer Stock Is Too Hot but It’s Definitely Safe to Handle Here
PFE stock has had 2 recent mega rallies and it could have another one. But it's best asset is the support below and the dividend yield.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
157.27B
PE Ratio
-561.00
EPS
-0.05
Volume (Avg. Vol.)
17.27M
Day's Range
$27.67 - $28.09
52-Week Range
$25.20 - $37.80
Dividend & Yield
$1.64 (5.85%)
PFE Stock Predictions, Articles, and Pfizer News
As Vaccine Excitement Fades, Buy the Pullback in Pfizer
With its solid dividend yield and reasonable valuation, there's more to like about PFE stock than just Pfizer's pandemic catalyst.
Why Pfizer Stock Deserves a Spot In Your Portfolio
Pfizer has received its share of "no respect" treatment in 2020, but investors should be able to use that to their advantage going forward
Pfizer Stock Just Can’t Seem to Find a Cure for Investor Apathy
Here's my investor math: Huge medical breakthrough, plus huge PR and reputation breakthrough, plus insatiable demand for new product equals (or should equal) ... something. Something positive, anyway. Here's what we have instead: Borderline investor apathy.
Pfizer Stock Was a Long-Term Play Before Covid and Will Stay One After
The Covid-19 vaccine isn't a game-changer for Pfizer's valuation. That said, PFE stock was already cheap, and remains a strong buy.
Throw Growth Aside and See Pfizer Stock as Top Dividend and Cash Flow Play
Forget growth. Pfizer is an income play. Here's how to score some cash with PFE stock options.
Pfizer Stock and the Modern-Day Apollo Program
Much like the effort to put a man on the moon, the Covid-19 vaccine is historic. But there are other drivers for Pfizer stock as well.
Here’s How To Bull Trade The Dip In Pfizer Stock With Finesse
Sellers are striking Pfizer stock , even as it rolls out its novel coronavirus vaccine. Ignore the weakness, and buy with short puts.
The Question to Ask About COVID-19 Vaccine Stocks
The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started. Here's where to focus instead.
Why You Shouldn’t Yet Bet on the “Value Rally”
You’d have to take a “brave pill” to follow the "value rally" trend right now. Here's why and what you need to be focusing on instead.
5 Top Stock Trades for Thursday: SNAP, PFE, WKHS, BOX, SPOT
Snap, Pfizer, Workhorse, Box and Spotify were our top stock trades for Thursday. With that in mind, let's have a look at the charts.
Just Say No to Inovio Pharmaceuticals Stock
While INO stock has boasted a banner year, Inovio appears no closer to a Covid-19 vaccine than any of the other 150 contenders.
